PMID- 9420852 OWN - NLM STAT- MEDLINE DCOM- 19980122 LR - 20191102 IS - 1071-5576 (Print) IS - 1071-5576 (Linking) VI - 2 IP - 3 DP - 1995 May-Jun TI - Decreased response to vasopressin in the mesenteric resistance arteries of pregnant rats: effects of nifedipine and Bay K 8644. PG - 516-22 AB - OBJECTIVE: The purpose of this study was to investigate the contribution of potential-operated calcium (POC) channels in the mechanisms of the blunted effects of vasoconstrictors on mesenteric resistance arteries during normal pregnancy. METHODS: Mesenteric resistance arteries of virgin and term pregnant rats were set up under optimum passive tension in wire myograph systems. Cumulative concentration-response curves of arginine8-vasopressin (AVP) were measured in the absence and presence of nifedipine or Bay K 8644, a blocker and an activator, respectively, of POC channels. Binding studies were performed on membrane preparations of the mesenteric vascular bed of both groups of rats using saturation with [3H]nitrendipine. RESULTS: The maximal response to AVP was statistically similar in the two groups of arteries. Pregnancy shifted the AVP concentration-response curves to the right. Nifedipine (1 mumol/L) similarly reduced the maximum response to AVP in arteries of both groups, but produced a larger increase in EC50, the concentration inducing 50% maximum response, in resistance arteries of virgin versus pregnant rats. Bay K 8644 did not affect the maximum tension reached with AVP. However, it increased the effects of small concentrations of AVP in arteries of both groups. This was more important in tissues of virgin than pregnant rats. Binding of [3H]nitrendipine to membrane preparations of mesenteric vessels was not modified by pregnancy. CONCLUSION: Our results suggest a reduced functional influence of POC channels in the myotropic effects of AVP on mesenteric resistance arteries in pregnancy. This decreased influence of POC channels may contribute to resistance of the vasculature to vasopressor agents during pregnancy. FAU - St-Louis, J AU - St-Louis J AD - Laboratoire de Pharmacologie Vasculaire Perinatale, Hopital Ste-Justine, Montreal, Quebec, Canada. FAU - Pare, H AU - Pare H FAU - Roy, B AU - Roy B FAU - Brochu, M AU - Brochu M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Soc Gynecol Investig JT - Journal of the Society for Gynecologic Investigation JID - 9433806 RN - 0 (Calcium Channels) RN - 113-79-1 (Arginine Vasopressin) RN - 71145-03-4 (3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester) RN - 9B627AW319 (Nitrendipine) RN - I9ZF7L6G2L (Nifedipine) RN - X4W3ENH1CV (Norepinephrine) SB - IM MH - 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/*pharmacology MH - Animals MH - Arginine Vasopressin/*pharmacology MH - Calcium Channels/physiology MH - Cell Membrane/metabolism MH - Dose-Response Relationship, Drug MH - Female MH - In Vitro Techniques MH - Mesenteric Arteries/drug effects/*physiology MH - Muscle Contraction/drug effects MH - Muscle, Smooth, Vascular/drug effects/*physiology MH - Nifedipine/*pharmacology MH - Nitrendipine/metabolism MH - Norepinephrine/pharmacology MH - Pregnancy MH - Pregnancy, Animal/*physiology MH - Rats MH - Rats, Sprague-Dawley MH - Reference Values MH - Vascular Resistance/drug effects EDAT- 1995/05/01 00:00 MHDA- 1998/01/08 00:01 CRDT- 1995/05/01 00:00 PHST- 1995/05/01 00:00 [pubmed] PHST- 1998/01/08 00:01 [medline] PHST- 1995/05/01 00:00 [entrez] AID - 107155769400059A [pii] AID - 10.1016/1071-5576(94)00059-a [doi] PST - ppublish SO - J Soc Gynecol Investig. 1995 May-Jun;2(3):516-22. doi: 10.1016/1071-5576(94)00059-a.